http://reason.com/blog/2012/12/04/who-decides-what-a-drug-is-for-the-manuf
From the article:
In a case that could have broad ramifications for the pharmaceutical industry, a federal appeals court on Monday threw out the conviction of a sales representative who sold a drug for uses not approved by the Food and Drug Administration. The judges said that the ban on so-called off-label marketing violated the representative’s freedom of speech.
How many millions of dollars in fines that the Pharmas have paid for marketing a drug for “off-label” use… according to this court ruling… if it is upheld… there is no such thing as “off label”.
What are the poor insurance companies going to hang their hats on in denying high cost therapy as being “experimental” because it is being used off-label ?
What would be next… any therapy over $xxx.xx /month will required a PA?
Filed under: General Problems
Leave a Reply